The Evolving Treatment Landscape – From Symptom Management to Targeted Therapies
The Fibrodysplasia Ossificans Progressiva Market is undergoing a profound transformation, moving from a focus on palliative symptom management to targeted therapies that address the underlying pathology of heterotopic ossification. According to the MRFR report, the treatment landscape is segmented into corticosteroids, NSAIDs, bisphosphonates, and emerging targeted therapies. For...
0 Comments 0 Shares 322 Views 0 Reviews